The Food and Drugs Authority (FDA) says it would soon clamp down on non-iodised salt products on the markets to curb the occurrence of iodine deficiency disorders.
particularly when oppositely charged drug salts are mixed in relatively strong concentrations and when pH values of dilutions create more than 1% of nonionized drug forms. a For the purposes of ...